Germany Cannabis

Editor’s note: This article has been updated to reflect the accurate percentage of the German population participating in the medical cannabis market. Shares of Aurora Cannabis Inc (NASDAQ:ACB) fell roughly 20% on Wednesday following the company's fiscal Q4 and full-year 2025 earnings report...

Germany's newly formed CDU/CSU-SPD coalition will not roll back the country's cannabis legalization law, known as CanG, despite internal pressure from Bavaria's conservative leadership. Instead, the government will proceed with a scheduled evaluation of the policy in late 2025, leaving the current...

Canada’s dried flower exports have seen impressive growth, doubling year-over-year in 3Q24, with the sector hitting record levels in October. According to Pablo Zuanic, senior analyst at Zuanic & Associates, “The strong growth in dried flower exports signals a thriving international...

In a recent note, senior analyst Pablo Zuanic digs into the financial standing and valuation of Village Farms (NASDAQ:VFF), the only cannabis company anointed by the Drug Enforcement Agency (DEA) as one of the 25 DPs ("designated participants") in the administrative hearing for the rescheduling of...

The German Medical Association is calling on the next government to reverse partial cannabis legalization, reported ZdfHeute, according to translation. “The legal regulations for the legalization of cannabis as a recreational substance must be completely revoked," the association wrote in a...

The Conference of Justice Ministers on Thursday approved a proposal from Baden-Württemberg and Berlin to revise the cannabis law, writes SWR, according to translation. What happened: The Baden-Württemberg Justice Minister Marion Gentges (CDU) and Berlin's Senator for Justice Felor Badenberg...

Berlin’s Senator for Justice Felor Badenberg recently criticized Germany's cannabis law. According to Badenberg, contrary to the objectives of the law, legalization actually made the fight against the black market and organized crime more difficult, writes Zeit online, according to...

Portugal-based medical marijuana grower Gro-Vida teamed up with Canopy Growth Germany GmbH, a subsidiary of cannabis giant Canopy Growth Corporation (NASDAQ:CGC). This agreement is a key step for Gro-Vida to position itself in Germany’s growing medical marijuana market while supporting Canopy...

Germany’s medical cannabis imports reached 20.1 tons in Q3 2024, a substantial increase from previous quarters. This surge follows the April 2024 revision of the country’s narcotics law, which has facilitated greater access to medical cannabis.  Despite this growth, medical cannabis...

Commissioner on Narcotic Drugs at the Federal Ministry of Health Burkhard Blienert has invited delegations from various European countries to exchange experiences on regulating cannabis for non-medical purposes. According to the official press release, participants include ministerial...

Tilray Medical, a division of Tilray Brands (NASDAQ:TLRY), announced the launch of its first commercial medical cannabis products cultivated in Germany. The debut comes from its Aphria RX facility, marking a milestone under the country's recently updated cultivation regulations, MedCanG. New...

International medical cannabis company IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) announced its financial results on Thursday for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). “While the 66%...

Members of the German cannabis industry shared their plans and opinions with Benzinga on what looks to be an uncertain political landscape following the recent collapse of Germany’s coalition government. In this article, we look at the situation and lay out the scenarios, with the leading...

After seven years of navigating an uncertain landscape, Munich-based Drapalin Pharmaceuticals GmbH has emerged as the sole licensed cannabis distributor in Bavaria where 13 million people live. Co-founded and co-run by Ivan Garev, Drapalin has grown significantly since cannabis was rescheduled as...

Aurora Cannabis Inc. (NASDAQ:ACB) recently reported strong quarterly earnings that outpaced market expectations, despite a downturn across the cannabis sector.  Aurora's share price fell 18% following the earnings report, reflecting broader sector pressures, with the MSOS ETF down 29%. As of...